Axsome Therapeutics’ (AXSM) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. HC Wainwright currently has a $180.00 price target on the stock. A number of other equities research analysts have also recently commented on AXSM. Cantor Fitzgerald restated an overweight rating […]
More Stories
Seizert Capital Partners LLC Sells 1,652 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Seizert Capital Partners LLC decreased its position in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.6% during the...
Alphabet Inc. (NASDAQ:GOOGL) Stock Position Trimmed by Symphony Financial Services Inc.
Symphony Financial Services Inc. decreased its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 16.7% in the 4th quarter,...
Sterling Infrastructure, Inc. (NASDAQ:STRL) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Sterling Infrastructure, Inc. (NASDAQ:STRL – Free Report) by 13.8% during...
Paragon Private Wealth Management LLC Buys 868 Shares of JPMorgan Chase & Co. (NYSE:JPM)
Paragon Private Wealth Management LLC grew its stake in JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 26.1% in...
Independent Advisor Alliance Takes Position in Carvana Co. (NYSE:CVNA)
Independent Advisor Alliance bought a new position in shares of Carvana Co. (NYSE:CVNA – Free Report) during the 4th quarter,...
Independent Advisor Alliance Purchases 11,127 Shares of JPMorgan Chase & Co. (NYSE:JPM)
Independent Advisor Alliance lifted its position in shares of JPMorgan Chase & Co. (NYSE:JPM) by 6.5% in the fourth quarter,...